MORGAN STANLEY PLC/CALL/PFIZER INC/62/0.1/20.06.25 Stock

Warrant

DE000MB5GWY2

Market Closed - Börse Stuttgart 11:34:02 2024-06-07 am EDT
0.013 EUR -7.14% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/62/0.1/20.06.25
Current month+8.33%
1 month-27.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 0.013 -7.14%
24-06-06 0.014 0.00%
24-06-05 0.014 +16.67%
24-06-04 0.012 -7.69%
24-06-03 0.013 +8.33%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 11:34 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB5GWY
ISINDE000MB5GWY2
Date issued 2023-04-11
Strike 62 $
Maturity 2025-06-20 (376 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.124
Lowest since issue 0.01
Spread 0.027
Spread %67.50%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.58 USD
Average target price
31.92 USD
Spread / Average Target
+11.67%
Consensus